Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at www.pharmathene.com.
PHARMATHENE, INC.
CONSOLIDATED BALANCE SHEETS
December 31,
2008 2007
ASSETS
Current assets:
Cash and cash equivalents $19,752,404 $40,582,643
Restricted Cash 12,000,000 -
Short-term investments 3,190,912 12,153,945
Accounts receivable 8,890,077 4,005,694
Other receivables 1,391,512 1,240,069
Prepaid expenses and other
current assets 917,125 492,294
Total current assets 46,142,030 58,474,645
Long-term restricted cash 1,250,000 -
Property and equipment, net 5,313,219 6,571,024
Patents, net 925,489 1,312,991
Other long term assets 220,531 183,588
Deferred costs
'/>"/>
| SOURCE PharmAthene, Inc. Copyright©2009 PR Newswire. All rights reserved |